Opioids and Cannabinoids for Neurologic Pain: What Neurologists Need to Know in 2024
This 2024 CME review focuses on opioid therapy neurologic pain, synthesizing current evidence and guidelines for neurologists. It highlights risks of abrupt opioid tapering and the investigational role of cannabinoids. The review supports a cautious,…
WJBF – New Study Highlights Cannabis Safety Clinical Guidelines
This article discusses cannabis safety clinical guidelines based on a new study from Washington State University. The research holds high clinical relevance for evidence-based medicine. Understanding these guidelines is essential for informed clinical…
Medical Cannabis Use in Autism: Patient Characteristics and Guidelines
This study examines medical cannabis prescribing patterns autism in a large Israeli HMO. It highlights patient characteristics and alignment with national guidelines. Evidence for medical cannabis use in autism remains limited but growing.
What This Lancet Review Really Says About Cannabinoids in Psychiatry – CED Clinic
The cannabinoids mental health evidence from The Lancet review highlights mixed quality research with some promising findings. This review influences clinical guidelines and provider perspectives on cannabis therapeutics in psychiatry. Understanding this…
Understanding Clinical Relevance in Cannabis Research
This article discusses clinical relevance cannabis research focusing on a massive new study with no evidence supporting medicinal cannabis treatment. It highlights the importance of evidence-based medicine and clinical guidelines in interpreting cannabis…